Although further investigation into neuronal and muscle-specific consequences of C9orf72 deficiency are needed, these findings highlight the importance of preserving C9orf72 levels in ALS patients undergoing treatments with C9orf72 antisense oligonucleotide (ASO) strategies [56]. Here, C9orf72 is linked to amyotrophic lateral sclerosis.